NL-OMON24910已完成不适用
Prospective evaluation of the predictive value of a circulating tumor cell (CTC) sensitivity profile to Cisplatin chemotherapy in metastatic breast cancer patients
Erasmus MC Cancer Center, Department of Medical Oncology0 个研究点目标入组 100 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 100
研究概览
简要总结
de Kruijff et al. Prospective Evaluation of a Circulating Tumor Cell Sensitivity Profile to Predict Response to Cisplatin Chemotherapy in Metastatic Breast Cancer Patients. Frontiers in Oncology (2021)
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •Female patient with metastatic breast cancer who has been pretreated with at least anthracycline and taxane-based chemotherapy in the adjuvant and/or metastatic setting
- •- Measurable disease according to RECIST 1.1, i.e. at least one measurable lesion on CT-scan where the longest diameter in the plane of measurement is a minimum size of 10mm
排除标准
- •- Other anticancer chemotherapy, use of biological response modifiers, or immunotherapy within two weeks prior to treatment start. Hormonal antitumor treatment within one week prior to treatment start.
- •- Hearing loss of at least Common Terminology Criteria for Adverse Events (CTCAE) grade 2
研究者
相似试验
招募中
不适用
Bespoke ctDNA Assay for Recurrence and Treatment Response Monitoring in Advanced Epithelial Ovarian CancerOvarian CancerNCT05446545Fudan University139
已完成
不适用
Circulating Tumour Cells as Biomarkers to Predict Prostate Cancer Metastasis for Treatment Stratification of CancerProstate CancerNCT05533515Queen Mary University of London330
终止
不适用
Prognostic Value of CTC in HNSCC PatientsRecurrenceMetastasisDeathNCT01884129Chang Gung Memorial Hospital53
已完成
不适用
Prospective Validation of Circulating Tumor Cells & Circulating Endothelial Cells as Biomarkers in Renal CancerClear Cell Renal CancerCirculating Tumor CellsCirculating Endothelial CellsPrognostic BiomarkersPredictive BiomarkersNCT02499458Lawson Health Research Institute44
已完成
不适用
Circulating Tumor Cells in High-Risk Prostate Cancer Treated With High-dose Radiotherapy and Hormone TherapyPatients With High-risk Prostate CancerNCT01800058Fundación de Investigación Biomédica - Hospital Universitario de La Princesa68